A scientific experiment to study the effects of the drug Ropivacaine with two additives, Clonidine and Dexmedetomidine, instilled inside abdomen in patients undergoing elective laparoscopic cholecystectomy
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/11/047103
- Lead Sponsor
- Department of Anesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All ASA grade I and grade II patients between 19-60 years age group
Exclusion Criteria
·All ASA grade III and IV patients.
·Diabetes and Hypertension.
·Cardiovascular, respiratory and neurological disorders.
·Obesity (BMI >30kg/m2).
·Drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umerical Rating Score (NRS) <br/ ><br>Time for first request of analgesiaTimepoint: 24 hours
- Secondary Outcome Measures
Name Time Method Adverse effectsTimepoint: 24 hours;Patient satisfactionTimepoint: 48 hours